Study Stopped
too few patients undergoing medical abortion (\< 5 per year)
Voluntary Termination of Pregnancy: Comparison of Women's Experiences Depending on the Method Used.
VECUVG
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Voluntary termination of pregnancy (abortion) is a major current societal issue. This is a very common situation, around 225,000 abortions are carried out every year in France. The French law of March 2, 2022 (no. 2022-295) extended the legal deadline for voluntary termination of pregnancy from 14 to 16 weeks of amenorrhea (SA). The recommendations have not been updated following this legal extension, the centers performing abortions are therefore free regarding the protocol for carrying out these so-called late abortions (between 14 and 16 weeks). There are two pregnancy termination techniques practiced in France: medical or surgical. The drug method consists of drug-induced expulsion of the pregnancy. This method is carried out in the delivery room, and lasts several hours. The surgical method consists of an endouterine aspiration carried out in the operating room, which lasts approximately 30 minutes. At the Toulouse University Hospital, as in many centers in France, it is the patient who chooses the method, apart from a contraindication to one or other of these methods. Due to the recent nature of these late abortions, practitioners still have little experience of the consequences of these procedures and this compromises the quality of the information provided to patients. It is necessary to have quality studies to improve knowledge about late abortions, in order to be able to correctly inform patients and allow them to make an informed choice regarding the method used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedStudy Start
First participant enrolled
December 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedJuly 21, 2026
July 1, 2026
Same day
November 10, 2023
July 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of anxiety or depressive disorder depending on the method used, surgical or medicinal
Anxiety will be measured using Hospital Anxiety and Depression Scale (HADS)
At the inclusion visit before abortion and 3 weeks after abortion
Study Arms (1)
Experimental: Patient treated at the Toulouse University Hospital for an abortion
Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound) presenting with a single and evolving pregnancy.
Interventions
A questionnaire is offered to patients who meet the eligibility criteria and who have given their non-objection during the abortion request consultation. This questionnaire includes questions for screening for anxiety and depressive disorders.
Eligibility Criteria
Patient coming for Voluntary termination of pregnancy (abortion)
You may qualify if:
- Any adult patient
- Having given her non-opposition after clear and fair information (patient who understands and reads French)
- Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound)
- Singleton pregnancy
- Progressive pregnancy
You may not qualify if:
- Protected adult patient (guardianship, curatorship, protection of justice)
- Developing psychiatric pathologies
- Fetal anomaly detected
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lola LOUSSERT CHAMBRE, MD
University Hospital, Toulouse
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2023
First Posted
November 18, 2023
Study Start
December 20, 2024
Primary Completion
December 20, 2024
Study Completion
December 20, 2024
Last Updated
July 21, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share